Page last updated: 2024-11-13

oligomycin a

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID52947716
CHEMBL ID1255855
CHEBI ID28285
SCHEMBL ID21863699
MeSH IDM0097725

Synonyms (29)

Synonym
einecs 209-437-3
rp-32705
brn 5702132
579-13-5
oligomycin a ,
nsc-717694
CHEMBL1255855
unii-05hqs4ai99
nsc 717694
05hqs4ai99 ,
bdbm50442906
mch-32
oligomycin a [mi]
mch 32
(1r,4e,5's,6s,6's,7r,8s,10r,11r,12s,14r,15s,16r,18e,20e,22r,25s,27r,28s,29r)-22-ethyl-7,11,14,15-tetrahydroxy-6'-((r)-2-hydroxypropyl)-5',6,8,10,12,14,16,28,29-nonamethyl-3',4',5',6'-tetrahydro-2,26-dioxaspiro[bicyclo[23.3.1]nonacosane-27,2'-pyran]-4,18,2
oligomycin-a
(1r,4e,5's,6s,6's,7r,8s,10r,11r,12s,14r,15s,16r,18e,20e,22r,25s,27r,28s,29r)-22-ethyl-7,11,14,15-tetrahydroxy-6'-[(2r)-2-hydroxypropyl]-5',6,8,10,12,14,16,28,29-nonamethyl-3',4',5',6'-tetrahydro-3h,9h,13h-spiro[2,26-dioxabicyclo[23.3.1]nonacosa-4,18,20-tr
CHEBI:28285 ,
DTXSID80891317 ,
EX-A2133
BS-17677
CS-0007502
HY-16589
Q27236113
SCHEMBL21863699
AC-35836
AKOS037748854
(1r,4e,5's,6s,6's,7r,8s,10r,11r,12s,14r,15s,16r,18e,20e,22r,25s,27r,28s,29r)-22-ethyl-7,11,14,15-tetrahydroxy-6'-((2r)-2-hydroxypropyl)-5',6,8,10,12,14,16,28,29-nonamethyl-3',4',5',6'-tetrahydro-3h,9h,13h-spiro(2,26-dioxabicyclo(23.3.1)nonacosa-4,18,20-tr
dtxcid301030473

Research Excerpts

Overview

Oligomycin A is a well-known Csub interactor that has been chemically modified in-depth for proposed new pharmacological approaches against cardiac reperfusion injury.

ExcerptReferenceRelevance
"Oligomycin A is a well-known Csub interactor that has been chemically modified in-depth for proposed new pharmacological approaches against cardiac reperfusion injury."( 1,3,8-Triazaspiro[4.5]decane Derivatives Inhibit Permeability Transition Pores through a F
Bouhamida, E; Branchini, A; Campo, G; Giorgi, C; Morciano, G; Patergnani, S; Pedriali, G; Pinotti, M; Pinton, P; Ramaccini, D; Scala, A; Tonet, E; Trapella, C; Tremoli, E; Turrin, G, 2023
)
1.63
"Oligomycin A is a potent antibiotic and antitumor agent. "( Stereochemistries and Biological Properties of Oligomycin A Diels-Alder Adducts.
Belov, NM; Dezhenkova, LG; Grammatikova, NE; Lysenkova, LN; Malyshev, VI; Medvedev, MG; Omelchuk, OA; Scherbakov, AM; Shchekotikhin, AE, 2021
)
2.32

Treatment

ExcerptReferenceRelevance
"The oligomycin A treatment causes mitochondrial loss, increase in reactive oxygen species (ROS), destabilization/reorganization of the actin microfilaments and, finally, autophagic cell death."( Oligomycin A and the IPLB-LdFB insect cell line: actin and mitochondrial responses.
de Eguileor, M; Malagoli, D; Ottaviani, E; Tettamanti, G, 2008
)
2.27

Dosage Studied

ExcerptRelevanceReference
" Dose as moles per cell can also provide additional information not easily obtainable with traditional dosing metrics."( Moles of a Substance per Cell Is a Highly Informative Dosing Metric in Cell Culture.
Buettner, GR; Doskey, CM; van 't Erve, TJ; Wagner, BA, 2015
)
0.42
"Here, 1,4-benzoquinone and oligomycin A are used as model compounds to investigate moles per cell as an informative dosing metric."( Moles of a Substance per Cell Is a Highly Informative Dosing Metric in Cell Culture.
Buettner, GR; Doskey, CM; van 't Erve, TJ; Wagner, BA, 2015
)
0.71
"Moles per cell is a useful and informative dosing metric in cell culture."( Moles of a Substance per Cell Is a Highly Informative Dosing Metric in Cell Culture.
Buettner, GR; Doskey, CM; van 't Erve, TJ; Wagner, BA, 2015
)
0.42
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (3)

RoleDescription
EC 3.6.3.14 (H(+)-transporting two-sector ATPase) inhibitorAn EC 3.6.3.* (acid anhydride hydrolase catalysing transmembrane movement of substances) inhibitor that interferes with the action of H(+)-transporting two-sector ATPase inhibitor (EC 3.6.3.14).
antineoplastic agentA substance that inhibits or prevents the proliferation of neoplasms.
nematicideA substance used to destroy pests of the phylum Nematoda (roundworms).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (4)

ClassDescription
oligomycinAny of the 26-membered ring macrolides produced by Streptomyces species that can be toxic to other organisms through their ability to inhibit mitochondrial membrane-bound ATP synthases.
diketoneA compound that contains two ketone functionalities.
pentolA polyol with five hydroxy groups.
antibiotic antifungal agentHeteroorganic entities that are microbial metabolites (or compounds derived from them) which have significant antifungal properties.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (2)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Solute carrier organic anion transporter family member 1B3Homo sapiens (human)Ki0.44000.08002.46889.8000AID977604
Solute carrier organic anion transporter family member 1B1Homo sapiens (human)Ki0.25000.04401.36305.0000AID977601
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (9)

Processvia Protein(s)Taxonomy
xenobiotic metabolic processSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
heme catabolic processSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
xenobiotic metabolic processSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
monoatomic ion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
organic anion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
bile acid and bile salt transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
prostaglandin transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
heme catabolic processSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
sodium-independent organic anion transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
transmembrane transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
thyroid hormone transportSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (6)

Processvia Protein(s)Taxonomy
serine-type endopeptidase inhibitor activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B3Homo sapiens (human)
organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
bile acid transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
prostaglandin transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
sodium-independent organic anion transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
thyroid hormone transmembrane transporter activitySolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (4)

Processvia Protein(s)Taxonomy
plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 1B3Homo sapiens (human)
plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
basal plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
basolateral plasma membraneSolute carrier organic anion transporter family member 1B1Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (14)

Assay IDTitleYearJournalArticle
AID977599Inhibition of sodium fluorescein uptake in OATP1B1-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1427460Induction of AMPK phosphorylation at Thr-172 residue in human HCT116 cells at 2 uM after 30 mins in absence of glucose by immunoblot method2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis.
AID1337888Cytotoxicity against human SH-SY5Y cells assessed as reduction in cell viability after 24 hrs by MTT assay
AID680288TP_TRANSPORTER: increase in Calcein-AM intracellular accumulation (Calcein-AM: 0.5 uM, Oligomycin: 5 uM) in MDR1-expressing NIH-3T3 cells2004Biochemical and biophysical research communications, Mar-19, Volume: 315, Issue:4
Distinct groups of multidrug resistance modulating agents are distinguished by competition of P-glycoprotein-specific antibodies.
AID977601Ki values for sodium fluorescein (10 uM) uptake in OATP1B1-transfected CHO cells2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID521051Antimicrobial activity against Trypanosoma brucei brucei 427 bloodstream form assessed as reduction in mitochondrial membrane potential at 4 uM after 10 mins using rhodamine 123 exclusion test relative to control2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei.
AID681551TP_TRANSPORTER: inhibition of Taurocholate uptake (Taurocholate: 10 uM, Oligomycin: 0.01mg/mL) in Ntcp-expressing HPCT-1E3 cells1996European journal of cell biology, May, Volume: 70, Issue:1
Functional characterization of the hepatic sodium-dependent taurocholate transporter stably transfected into an immortalized liver-derived cell line and V79 fibroblasts.
AID977604Ki values for sodium fluorescein (10 uM) uptake in OATP1B3-transfected CHO cells2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID1427459Induction of AMPK phosphorylation at Thr-172 residue in human HCT116 cells at 2 uM after 30 mins in glucose supplemented media by immunoblot method2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis.
AID1667605Inhibition of F0 subunit in F0F1 ATP synthase in human NCI-H460 cells assessed as inhibition of oxygen consumption rate at 1 uM by seahorse XFe96 analyser based assay2020Bioorganic & medicinal chemistry letters, 05-01, Volume: 30, Issue:9
Synthesis and anti-OXPHOS, antitumor activities of DLC modified spinosyn derivatives.
AID521058Antimicrobial activity against Trypanosoma brucei brucei 427 bloodstream form assessed as inhibition of mitochondrial ATPase activity at 50 uM after 10 mins2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei.
AID977602Inhibition of sodium fluorescein uptake in OATP1B3-transfected CHO cells at an equimolar substrate-inhibitor concentration of 10 uM2013Molecular pharmacology, Jun, Volume: 83, Issue:6
Structure-based identification of OATP1B1/3 inhibitors.
AID521057Antimicrobial activity against Trypanosoma brucei brucei 427 bloodstream form assessed as reduction in mitochondrial membrane potential at 4 uM after 1 min using rhodamine 123 exclusion test2008Antimicrobial agents and chemotherapy, Mar, Volume: 52, Issue:3
The mitochondrion is a site of trypanocidal action of the aromatic diamidine DB75 in bloodstream forms of Trypanosoma brucei.
AID1427457Effect on ATP homeostasis in human HCT116 cells assessed as reduction in ATP level at 2 uM after 3 hrs in glucose supplemented media by ATP bioluminescent assay2017Bioorganic & medicinal chemistry, 03-15, Volume: 25, Issue:6
Benzimidazole inhibitors from the Niclosamide chemotype inhibit Wnt/β-catenin signaling with selectivity over effects on ATP homeostasis.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (77)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (3.90)18.7374
1990's4 (5.19)18.2507
2000's15 (19.48)29.6817
2010's42 (54.55)24.3611
2020's13 (16.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 35.42

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index35.42 (24.57)
Research Supply Index4.38 (2.92)
Research Growth Index5.19 (4.65)
Search Engine Demand Index43.27 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (35.42)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other79 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]